Document is current

Any future updates will be listed below

Cost-effectiveness of tolvaptan for the treatment of hyponatraemia secondary to syndrome of inappropriate antidiuretic hormone secretion in Sweden

Crossref DOI link: https://doi.org/10.1186/s12902-016-0104-z

Published Online: 2016-05-16

Published Print: 2016-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark